Депрессивные и невротические расстройства, их распространенность, коморбидность и клинические проявления при некоторых соматических заболеваниях

Полный текст:   Только для подписчиков

Рекомендуемое оформление библиографической ссылки:

Атькова Е.О., Барденштейн Л.М., Маев И.В., Осипова Н.Н. Депрессивные и невротические расстройства, их распространенность, коморбидность и клинические проявления при некоторых соматических заболеваниях // Российский психиатрический журнал. 2025. №4. С. 44-55.

Аннотация

В научном обзоре с целью определения наиболее актуальных проблем для дальнейших исследований были проанализировано 83 отечественных и зарубежных источника, касающихся депрессивных и невротических расстройств, их распространенности, коморбидности, клиники при соматических заболеваниях. Авторы пришли к заключению о том, что наиболее значимыми и наименее изученными являются вопросы, связанные с этиологией, патогенезом и клиническими проявлениями тревожно-депрессивных расстройств при соматических заболеваниях, в том числе, при синдроме раздраженного кишечника.

Ключевые слова распространенность депрессивных и невротических расстройств; заболеваемость; коморбидность; соматические заболевания; синдром раздраженного кишечника

Литература

1. Bardenshtein LM. Klinika, dinamika i terapiya distimii. In: YuA Aleksandrovsky, LM Bardenshtein, AS Avedisova (eds). Psikhofarmakoterapiya pogranichnykh psikhicheskikh rasstroistv. Moscow, 2000. P. 136–63. (In Russ.) 2. Shilova OV, Khodzhaev AV, Kaminskaya YuM, Shadenko VN, Shaparevich AS. Rasprostranennost' depressivnykh rasstroistv i kachestvo zhizni, svyazannoe so zdorov'em, u vzroslogo naseleniya Respubliki Belarus' (po dannym kliniko-epidemiologicheskogo issledovaniya 2020–2022 godov. Minsk: Respublikanskii nauchno-prakticheskii tsentr psikhicheskogo zdorov'ya; 2022. Р. 185–201. (In Russ.) 3. Shalnova SA, Evtifeeva SE, Deev AD, Artamonova GV, et al. Rasprostranennost' trevogi i depressii v razlichnykh regionakh Rossiiskoi Federatsii i ee assotsiatsii s sotsial'no-demograficheskimi faktorami (po dannym issledovaniya ESSE-RF). Terapevticheskii arkhiv. 2014;86(12):53–60. (In Russ.) DOI: 10.17116/terarkh2014861253-60 4. Kornetov NA. [Semiotics, diagnosis and tactics of therapy of depressive disorder in clinical medicine]. Byulleten' sibirskoi meditsiny [Bulletin of Siberian Medicine]. 2014;13(3):5–24. (In Russ.) 5. Gilbody S, Whitty P, Grimshaw J, Thomas R. Educational and Organizational Interventions to Improve the Management of Depression in Primary Care: A Systematic Review. Jama. 2003;289(23):3145–51. 6. World Health Organisation. The World Health Report, 1999. Geneva: WHO, 1999. URL: https://www.who.int/mental_health/in_the_workplace/en/ (accessed on: 20.04.2025). 7. Laura Entis. Depression Is Now the World's Most Widespread Illness URL: http://fortune.com/2017/03/30/depression-rate/ (accessed on: 20.04.2025). 8. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858. 9. GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9(2):137–50. 10. Mental disorders: World Health Organization fact sheet. 2022. URL: https://www.who.int/ru/news-room/factsheets/detail/mental-disorders (accessed on: 20.04.2025). 11. Aleksandrovsky YuA. Psikhicheskie rasstroistva v obshchemeditsinskoi praktike i ikh lechenie. Moscow, GEOTAR-Med; 2004. 235 p. (In Russ.) 12. Demcheva NK, Kalinina EV. [Clinical and epidemiological characteristics of mental disorders in persons with a newly diagnosed diagnosis and factors affecting the primary appeal for psychiatric care]. Psikhicheskoe zdorov'e [Mental health]. 2010;7(50):28–35. (In Russ.) 13. Demcheva NK, Orlova NV. [Neurotic disorders in the urban population (clinical and epidemiological, pharmacoepidemiological and organizational aspects]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2011;6:42–50. (In Russ.) 14. Bogushevskaya YuV. Kliniko-dinamicheskie i terapevticheskie aspekty somatizirovannykh rasstroistv [PhD thesis]. [Moscow (Russia)]; 2007. 25 p. (In Russ.) 15. Khlebnikova LYu. Klinicheskaya kharakteristika atipichnykh (maskirovannykh) depressivnykh rasstroistv u bol'nykh v obshchei meditsinskoi praktike [PhD thesis]. [Moscow (Russia)]; 2004. 24 р. (In Russ.) 16. Mental health. Fact Sheet/World Health Organization. Geneva: WHO, 2019. URL: https://www.who.int/ru/news-room/fact-sheets/detail/mental-health- strengtheningour-response (accessed on: 20.04.2025). 17. Chen CM, Slater M, Castle I-J, Grant BF. Alcohol Use and Alcohol Use Disorders in the United States: Main Findings from the 2012–2013 National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). Bethesda (MD): National Institute on Alcohol Abuse and Alcoholism, 2016. URL: https://pubs.niaaa.nih.gov/publications/NESARC_DRM/NESARC3DRM.pdf (accessed on: 20.04.2025). 18. Case A, Deaton A. Rising morbidity and mortality in midlife among whitenon-HispanicAmericans in the 21st century. Proc Nat l AcadSciUSA. 2015;112(49):15078–83. 19. The World Health Organization. Depression. Newsletter No 369. 2012. URL: http://www.who.int/mediacentre/factsheets/fs369/ru/ (accessed on: 10.04.2025). 20. Mojtabai R, Olfson M, Han B. National trends in the prevalence and treatment of depression in adolescents and young adults. Pediatrics. 2016;138(6):e20161878. 21. Kessler RC. The costs of depression. PsychiatrClin North Am. 2012;35(1):1–14. 22. Qaseem A, Barry MJ, Kansagara D. Clinical Guidelines Committee of the American College of Physicians. Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: a clinical practice guideline from the American College of Physicians. AnnInternMed. 2016;164(5):350–9. 23. Nübel J, Müllender S, Hapke U, et al. Epidemie der Depression? Nervenarzt. 2019;90:1177–86. 24. Jacobi F, Nübel J, Müllender S. Veränderungen und Variationen der Häufigkeit psychischer Störungen in Deutschland – Krankenkassenstatistiken und epidemiologische Befunde. Public Health Forum. 2015;23(2):90–3. DOI: 10.1515/pubhef-2015-0029 25. Leon. La dépression en France chez les 18–75 ans: résultats du baromètre s anté 2017. BEH. 2018. Р. 32–33. 26. Andryushenko AV, Drobizhev MYu, Dobrovolsky AV. [Comparative evaluation of the CES-D, BDI and HADS (d) scales in the diagnosis of depression in general medical practice]. Zhurnal nevrologii i psikhiatrii [Journal of Neurology and Psychiatry]. 2003;5:11–7. (In Russ.) 27. Vorobyova OV. Klinicheskie osobennosti depressii v obshchemeditsinskoi praktike (po rezul'tatam programmy «KOMPAS»). Consilium Medicum. 2004;6(2). URL: https://con-med.ru/magazines/consilium_medicum/21244/ (accessed on: 20.04.2025). (In Russ.) 28. Kempinski A. Psikhopatologiya nevrozov. Warsaw, 1975. 400 р. (In Russ.) 29. Zozulya TV, Rothstein VG, Sulitsky AI. K probleme rasprostranennosti psikhicheskikh rasstroistv. Zhurnal nevropatologii i psikhiatrii [Journal of Neuropathology and Psychiatry]. 1994;94(4):99–103. (In Russ.) 30. Filyk VS. Nevrozy u zhitelei sel'skoi mestnosti (po dannym epidemiologicheskogo issledovaniya) i osobennosti organizatsii lechebno-reabilitatsionnykh meropriyatii. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. Moscow: MEDICINE, 1989;89(11):93–5. (In Russ.) 31. Lipgart NK, Filyk VS. Strukturnaya kharakteristika istinnoi i uchtennoi psikhiatricheskoi boleznennosti sel'skogo naseleniya sel'skokhozyaistvennykh raionov Ukrainy. In: Aktual'nye problemy epidemiologicheskikh issledovanii v psikhiatrii. Moscow, 1990. P. 124–6. (In Russ.) 32. Tabachnikov SI. Znachenie faktorov riska pri PNPR u rabotnikov proizvodstva. In: Pogranichnye psikhicheskie rasstroistva. Moscow, 1988. Р. 88–94. (In Russ.) 33. Zinkovsky AK, Vinogradova RN, Savelyev VF, et al. Opyt vyyavleniya pogranichnykh sostoyanii i organizatsiya lechebno-profilakticheskikh meropriyatii na promyshlennom predpriyatii. In: V Vserossiiskii s"ezd nevropatologov i psikhiatrov. Moscow, 1985. Р. 98–100. (In Russ.) 34. Churkin AA, Mikhailov VI, Kasimova LN. Psikhicheskoe zdorov'e naseleniya. Moscow-Khabarovsk, 2000. 376 p. (In Russ.) 35. Guardia D, Salleron J, Roelandt J-L, Vaiva G. [Prevalence of psychiatric and substance use disorders among three generations of migrants: Results from French population cohort]. Encephale. 2017;43:435–8. [In French] 36. Evdokimova TE, Tsygankov BD, Churkin AA. Nevroticheskie i somatoformnye rasstroistva u shakhterov. Kemerovo: Izdatel'stvo «Praktika»; 2011. 226 p. (In Russ.) 37. Salomon JA, Vos T, Hogan DR, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012;380:2129–43. 38. Samorodskaya II, Vatolina MA, Belov VB, Boytsov SA. Otsenka urovnya smertnosti ot psikhicheskikh zabolevanii i boleznei sistemy krovoobrashcheniya: problemy kodirovaniya i statisticheskogo ucheta sluchaev smerti. Problemy sotsial'noi gigieny, zdravookhraneniya i istorii meditsiny. 2014;5:3–7. (In Russ.) 39. GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. LancetPsychiatry. 2022;9(2):137–50. 40. Baxter, et al. Mental disorders as risk factors: assessing the evidence for the Global Burden of Disease Study. BMCMedicine. 2011;9:6–9, 134. 41. Murray C, Lopez A (eds). Global Burden of Disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. (Global Burden of Disease and Injury Series). Cambridge, MA: Harvard School of Public Health; 1996. 356 p. 42. Kazakovtsev BA, Holland VB, Kontsevoy VA, Kozyrev VN, et al. Psikhicheskie rasstroistva i rasstroistva povedeniya (F00-F99) (klass V MKB-10, adaptirovannyi dlya ispol'zovaniya v Rossiiskoi Federatsii). In: Tom 2. Perechen' diagnosticheskikh rubrik. Perekhodnaya tablitsa iz MKB-9 v MKB-10. Izdatel'stvo LRNTs «Feniks»; 1999. 143 p. (In Russ.) 43. Pirkis J, Spittal MJ, Keogh L, Mousaferiadis T, Currier D. Masculinity and suicidal thinking. Social Psychiatry and Psychiatric Epidemiology. 2017;52(3):319–27. 44. Pologiy BS. Suitsidal'naya situatsiya v Rossii: osnovnye tendentsii, regional'nye osobennosti, puti uluchsheniya. Psikhiatriya na etapakh reform: problemy i perspektivy. XVI s"ezd psikhiatrov Rossii. In: NG Neznanov, ed. Tezisy vserossiiskoi nauchno-prakticheskoi konferentsii s mezhdunarodnym uchastiem. Kazan', 23–26 sent. 2015 g. Saint Petersburg, 2015. P. 908–9. (In Russ.) 45. Boyd A, Van de Velde S, Vilagut G, de Graaf R, O’Neill S, Florescu S, Alonso J, Kovess-Masfety V. EU-WMH Investigators. Gender differences in mental disorders and suicidality in Europe: results from a large cross-sectional population-based study. J Affect Disord. 2015;173:245–54. 46. Nosova ES, Spasennikov BA, Alexandrova OY. Epidemiologiya samoubiistv v mire i faktory riska suitsidal'nogo povedeniya. Byulleten' Natsional'nogo nauchno-issledovatel'skogo instituta obshchestvennogo zdorov'ya imeni N.A. Semashko. 2021;4:4–17. (In Russ.) 47. Kornetov NA. Depressivnye rasstroistva (diagnostika, sistematika, semiotika, terapiya). 2-e izd., ispr. i dop. Tomsk: Sib. izd. Dom; 2003. 119 p. (In Russ.) 48. Malygin YaV, Tsygankov DB, Malygin VL, Shamov SA. [Multifactorial model of patient behavior in seeking medical help for depressive and neurotic disorders]. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2019;119(1-2):17–21. (In Russ.) 49. Alexandrovsky YuA. Pogranichnye psikhicheskie rasstroistva. Rukovodstvo dlya vrachei. Moscow: GEOTAR-Media; 2007. 720 p. (In Russ.) 50. Kibitov AO, Mazo GE, Rakitko AS, Kasyanov ED, et al. [Polygenic risk scales for depression based on GWAS with clinical validation: methodology and research design in the Russian population]. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2020;120(11):131–40. (In Russ.) 51. Baxter AJ, Scott KM, Vos T, Whiteford HA. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med. 2013;43:897–910. 52. Rotella F, Mannucci E. Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry. 2013;74(1):31–7. 53. Zeltyn AE, Veltischev DYu, Lisitsyna TA, Kovalevskaya OB, Seravina OF, Fofanova YuS, Nasonov EL. [Chronic stress and depression in patients with rheumatoid arthritis]. Social'naya i klinicheskaya psihiatriya [Social and clinical psychiatry]. 2009;2:69–76. (In Russ.) 54. Lisitsyna TA, Zeltyn AE, Veltischev DYu, Kovalevskaya OB, et al. [Cognitive impairments and disorders of the anxiety-depressive spectrum in patients with rheumatoid arthritis]. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2012;112(11-2):96–103. (In Russ.) 55. Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. Chest. 2013;144:766–77. 56. Neznanov NG, Bortsov AV. Diagnostika i lechenie trevozhno-depressivnykh rasstroistv v obshcheklinicheskoi praktike. St. Petersburg, 2005. 28 p. (In Russ.) 57. Neznanov NG, Kibitov AO, Rukavishnikov GV, Mazo GE. Prognosticheskaya rol' depressii v kachestve prediktora manifestatsii khronicheskikh somaticheskikh zabolevanii. Terapevticheskii arkhiv. 2018;90(12):122–32. (In Russ.) 58. Krasnov VN, Rogacheva TA, Melnikova TS. Dinamika patologicheskoi sistemy pri epilepsii s pozitsii dizregulyatsionnoi patologii. In: EI Gusev, GN Kryzhanovskii (eds). Dizregulyatsionnaya patologiya nervnoi sistemy. Moscow, 2009, P. 215–46. (In Russ.) 59. Schmitz B. Depressive disorders in Epilepsy. Ed. by M. Trimble and B. Schmitz. Guildford: CLARIUS PRESS LTD; 2002. Р. 19–34. 60. Robertson MM, Trimble MR. Depressive illness in patients with epilepsy: A review. Epilepsia. 1983;24(2):109–16. 61. Forsgren L, Nystrom L. An incident case referent study of epileptic seizures in adults. Epilepsy Res. 1990;6:66–81. 62. Selivanova GB. Komorbidnyi patsient v klinike vnutrennikh boleznei: serdechno-sosudistye zabolevaniya i trevoga. Kardiovaskulyarnaya terapiya i profilaktika. 2017;16(5): 84–9. (In Russ.) DOI: 10.15829/1728-8800-2017-5-84-89 63. Smulevich AB., Dubnitskaya EB. Depressii v obshchemeditsinskoi seti. Psikhicheskie rasstroistva v obshchei meditsine. 2010;1:3–8. (In Russ.) 64. Smulevich AB. Depressii v klinicheskoi praktike vrachei obshchemeditsinskikh spetsial'nostei. Rossiiskii meditsinskii zhurnal (RMZh). 2011;9:597. (In Russ.) 65. Sukiasyan SG, Margaryan SP, Manasyan NG, Babakhanyan AA, Pogosyan AN, Kirakosyan AL. Epidemiologiya depressii: bum rosta ili problemy diagnostiki? Erevan: Tsentr psikhicheskogo zdorov'ya «Stress»; 2010. 145 р. (In Russ.) 66. Ivanov SV. Depressivnye rasstroistva v onkologii (obzor). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. Spetsvypuski. 2012;112(11-2):104–9. (In Russ.) 67. Bardenshtein LM, Torchinov AM, Umakhanova MM. Klinicheskaya tipologiya depressivnykh rasstroistv u zhenshchin v perimenopauzal'nom periode. Allergologiya i immunologiya. 2005;6(2):269. (In Russ.) 68. Torchinov AM, Bardenshtein LM, Umakhanova MM, Kharkharova MA. Sovremennye aspekty depressivnykh rasstroistv u zhenshchin v perimenopauzal'nom periode. Psikhicheskie rasstroistva v obshchei meditsine. 2006;3:17–21. (In Russ.) 69. Maev IV, Bardenshtein LM, Antonenko OM, Kaplan RG. Psikhosomaticheskie aspekty zabolevanii zheludochno-kishechnogo trakta. Klinicheskaya meditsina. 2002;80:11:8–13. (In Russ.) 70. Maev IV, Burkov SG, Yurenev GL. Gastroezofageal'naya reflyuksnaya bolezn' i assotsiirovannaya patologiya. Moscow: Litterra; 2014. 352 р. (In Russ.) 71. Maev IV, Busarova GA, Andreev DN. Bolezni pishchevoda. Moscow: GEOTAR-Media; 2019. 648 р. (In Russ.) 72. Maev IV, Samsonov AA, Andreev DN. Bolezni zheludka. Moscow: GEOTAR-Media; 2015. 976 р. (In Russ.) 73. Karvasarskii BD. Nevrozy (rukovodstvo dlya vrachei). Moscow: Meditsina; 1980. 448 р. (In Russ.) 74. Istamanova TS. Funktsional'nye rasstroistva vnutrennikh organov pri nevrastenii. Moscow: Medgiz; 1958. 262 р. (In Russ.) 75. Ivashkin VT, Maev IV, Shelygin YuA, et al. Diagnostika i lechenie sindroma razdrazhennogo kishechnika (Klinicheskie rekomendatsii Rossiiskoi gastroenterologicheskoi assotsiatsii i Assotsiatsii koloproktologov Rossii). Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. 2021;31(5):74–95. (In Russ.) DOI: 10.22416/1382-4376-2021-31-5-74-95 76. Zamani M, Alizadeh-Tabari S. & Zamani V. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Aliment. Pharmacol. Ther. 2019;50:132–43. PubMed: 31157418 77. Heidi M. Staudacher,  Christopher J. Black, Scott B. Teasdale, Antonina Mikocka-Walus & Laurie Keefer. Irritable bowel syndrome and menthealth comorbidity – approach to multidisciplinary management. Nature Reviews Gastroenterology & Hepatology. 2023;20:582–96. 78. Chey WD, Keefer L, Whelan K & Gibson PR. Behavioral and diet therapies in integrated care for patients with irritable bowel syndrome, Gastroenterology. 2021;160:47–62. PubMed: 33091411 79. Nikolova VL, et al. The prevalence and incidence of irritable bowel syndrome and inflammatory bowel disease in depression and bipolar disorder: a systematic review and meta-analysis. Psychosom. Med. 2022;84:313–24. PubMed: 35067654 80. Midenfjord I, Borg A, Törnblom H & Simrén M. Cumulative effect of psychological alterations on gastrointestinal symptom severity in irritable bowel syndrome. Am. J. Gastroenterol. 2021;116:769–79. PubMed: 33982947 81. Mikocka-Walus A, Ford AC & Drossman DA. Antidepressants in inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 2020;17:184–92. PubMed: 32071420 82. Staudacher HM, Mikocka-Walus A & Ford AC. Common mental disorders in irritable bowel syndrome: pathophysiology, management, and considerations for future randomised controlled trials. Lancet Gastroenterol. Hepatol. 2021;6:401–10. PubMed: 33587890 83. Charilaos Chourpiliadis, MD Yu Zeng, MSc Anikó Lovik, et al. Metabolic Profile and Long-Term Risk of Depression, Anxiety, and Stress-Related isorders. JAMA Netw Open. 2024;7(4):e244525. DOI: 10.1001/jamanetworkopen.2024.4525

Метрики статей

Загрузка метрик ...

Metrics powered by PLOS ALM